[1]
2023. In silico Study of New Vascular Endothelial Growth Factor Receptor Inhibitors for The Treatment of Hepatocellular Carcinoma. Al Mustansiriyah Journal of Pharmaceutical Sciences. 23, 2 (May 2023), 214–220. DOI:https://doi.org/10.32947/ajps.v23i2.1023.